Institutional
Finepoint Capital LP
CIK 0001608126
$1.95B
Reported AUM
9
Positions
Q1 2026
Period
2026-05-14
Filed
The Brief · Finepoint Capital LP · Q1 2026
AI · grounded in 13F
Finepoint Capital LP established a new position in SOXX valued at $483.1M. The fund also opened a new position in QQQ for $366.4M and increased its stake in RXO by 7.29%. These additions coincided with the closure of its position in IWM, representing a $398M reduction. Additionally, the fund trimmed its holdings in QXO and SPY by 34.56% and 32.96% respectively.
Portfolio · Q1 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SPY | SPDR S&P 500 ETF TR | $729.46 | -1.54% | 20.48% | 75.54% | $685.9M | 35.13% | — | HELD |
| 2 | SOXX | ISHARES TR | $465.00 | -5.38% | 96.92% | 210.04% | $483.1M | 24.74% | — | HELD |
| 3 | QQQ | INVESCO QQQ TR | $661.73 | -2.04% | 22.54% | 83.19% | $366.4M | 18.76% | — | HELD |
| 4 | QXO | QXO INC | $13.40 | -5.96% | -28.56% | -69.62% | $269.1M | 13.78% | — | HELD |
| 5 | RXO | RXO INC | $22.29 | -1.55% | 50.93% | 19.16% | $147.3M | 7.54% | — | HELD |
| 6 | ANNAW | ALEANNA INC | — | — | -6.96% | — | $397K | 0.02% | — | HELD |
| 7 | ANNA | ALEANNA INC | $2.84 | 0.00% | -46.52% | -71.08% | $230K | 0.01% | — | HELD |
| 8 | MNYWW | MONEYHERO LIMITED | $0.04 | 0.00% | -47.37% | -96.71% | $76K | 0.00% | — | HELD |
| 9 | CLDI | CALIDI BIOTHERAPEUTICS INC | — | — | -98.48% | -99.99% | $249 | 0.00% | — | HELD |
Source: SEC EDGAR · accession 0000904454-26-000285. 13F discloses long positions only — shorts, foreign equities, and options are excluded.